Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effect of vildagliptin on copeptin in comparison to
glimepiride, and whether copeptin could be used as a marker for the efficacy of vildagliptin
in type 2 diabetes mellitus patients, and how copeptin correlates with other diabetic and
cardiac markers.